Richard Stewart - Mar 4, 2024 Form 4 Insider Report for ACHIEVE LIFE SCIENCES, INC. (ACHV)

Signature
Sandra Thomson as attorney-in-fact for Richard Stewart
Stock symbol
ACHV
Transactions as of
Mar 4, 2024
Transactions value $
$45,850
Form type
4
Date filed
3/6/2024, 04:49 PM
Previous filing
Jan 24, 2024
Next filing
Apr 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACHV Common Stock Purchase $45.9K +10K +35.09% $4.59 38.5K Mar 4, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACHV Common Stock Warrants (right to buy) Purchase $0 +10K $0.00 10K Mar 4, 2024 Common Stock 10K $4.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common shares reported on this Form 4 were purchased in a registered direct offering (the "RDO") at a price of $4.585, for an aggregate purchase price of $45,850 pursuant to a Securities Purchase Agreement (the "SPA") dated February 28, 2024. The SPA also provides for a concurrent private placement of warrants to purchase common shares (the "Private Placement Warrants") . The Private Placement Warrants are exercisable immediately upon issuance until the earlier of (x) three and one-half years after the date of issuance, and (y) 30 days following the Issuer's public disclosure of the acceptance of an NDA for cytisinicline by the FDA in a Day 74 Letter or equivalent correspondence.